H35.052 — Retinal neovascularization, unspecified, left eye
H35.052 is a billable, specific ICD-10-CM code for retinal neovascularization, unspecified, left eye. It is valid for submission on a claim.
Risk adjustment
H35.052 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
H35.052 is named in 28 Medicare coverage policies — 28 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52370Billing and Coding: Bevacizumab and biosimilars
- A52451Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU™aflibercept-ayyh, AHZANTIVE®aflibercept-abzv. ENZEEVU™aflibercept-mrbb, OPUVIZ™aflibercept-yszy and YESAFILI™ aflibercept-jbvf
- A53008Billing and Coding: Intraocular Bevacizumab
- A53060Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Code history
H35.052 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.
Related codes at this level
Codes that share H35.05. If H35.052 is not quite right, the correct code is usually one of these.
Questions about H35.052
- Is H35.052 a billable ICD-10-CM code?
- Yes. H35.052 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does H35.052 sit in the tabular list?
- Diseases of the eye and adnexa (H00-H59), in the block Disorders of choroid and retina (H30-H36).